Eurofins Scientific SE
ERFSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $555 | $310 | $780 | $1,057 |
| Dep. & Amort. | $597 | $664 | $504 | $451 |
| Deferred Tax | $0 | $0 | $0 | -$299 |
| Stock-Based Comp. | $138 | $138 | $136 | $131 |
| Change in WC | $51 | -$34 | $33 | -$7 |
| Other Non-Cash | -$22 | -$61 | -$317 | $177 |
| Operating Cash Flow | $1,319 | $1,018 | $1,136 | $1,510 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$454 | -$478 | -$660 | -$520 |
| Net Acquisitions | -$344 | -$158 | -$215 | -$533 |
| Inv. Purchases | $0 | $0 | -$2 | -$8 |
| Inv. Sales/Matur. | $0 | $0 | $2 | $8 |
| Other Inv. Act. | -$49 | -$45 | $19 | $18 |
| Investing Cash Flow | -$847 | -$681 | -$856 | -$1,034 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$360 | $549 | $385 | -$454 |
| Stock Issued | $0 | $8 | $15 | $36 |
| Stock Repurch. | -$272 | -$56 | -$16 | -$4 |
| Dividends Paid | -$96 | -$234 | -$192 | -$130 |
| Other Fin. Act. | -$363 | $338 | -$71 | -$359 |
| Financing Cash Flow | -$1,090 | $414 | -$311 | -$910 |
| Forex Effect | $9 | -$13 | -$1 | $39 |
| Net Chg. in Cash | -$608 | $738 | -$32 | -$396 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,221 | $483 | $515 | $911 |
| End Cash | $613 | $1,221 | $483 | $515 |
| Free Cash Flow | $791 | $468 | $476 | $990 |